Cover Image
市場調查報告書

組織工程取向醫療用品的全球市場:預測和機會 (2020年)

Global Tissue Engineered Medical Devices Market Forecast and Opportunities, 2020

出版商 Pharmaion 商品編碼 346833
出版日期 內容資訊 英文 193 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
組織工程取向醫療用品的全球市場:預測和機會 (2020年) Global Tissue Engineered Medical Devices Market Forecast and Opportunities, 2020
出版日期: 2015年12月11日 內容資訊: 英文 193 Pages
簡介

所謂組織工程,是為了將細胞、骨骼、生物活性分子加入活體內部完全具機能的組織、內臟器官,生醫材料的開發與實際加入的過程,以代替功能不全的組織、內臟器官為目的。組織工程取向醫療用品,比人造植入物適合性高,受醫生喜歡。還有人體的自體免疫反應發生的概率也變低。全球組織工程取向醫療用品的市場,估計2020年達到260億美元以上的規模。

本報告提供全球組織工程醫療用品的市場相關分析、市場整體規模、佔有率趨勢預測 (總計11年份) ,及各領域、各地區的詳細趨勢、主要企業簡介、結構的變化與新市場的市場機會、相關人員的建議的內容等彙整,為您概述為以下內容。

第1章 調查手法

第2章 分析師的見解

第3章 組織工程概要

第4章 全球組織工程取向醫療用品市場展望

  • 市場規模與其預測
    • 以金額為準
    • 以數量為準
  • 市場佔有率與其預測
    • 各應用領域 (整形外科、心血管、牙科、皮膚替代品等)
    • 各材料 (合成/天然生醫材料)
    • 各地區
    • 各企業
  • 品管政策

第5章 各部門的市場展望

  • 整形外科用、組織工程取向醫療用品市場展望
    • 市場規模與其預測
      • 以金額為準
      • 以數量為準
    • 市場佔有率與其預測
      • 各類型產品 (生技藥品、骨移植片、人工骨替代材料)
      • 各地區
      • 各企業
  • 心臟用、組織工程醫療取向用品市場展望
    • 市場規模與其預測
      • 以金額為準
      • 以數量為準
    • 市場佔有率與其預測
      • 各類型產品 (心臟瓣膜、手術用人工血管)
      • 各地區
      • 各企業
  • 牙科用、組織工程取向醫療用品市場展望
    • 市場規模與其預測
      • 以金額為準
      • 以數量為準
    • 市場佔有率與其預測
      • 各類型產品 (牙科再生膜、牙科骨移植片)
      • 各地區
      • 各企業
  • 皮膚替代品用、組織工程取向醫療用品市場展望
    • 市場規模與其預測
      • 以金額為準
      • 以數量為準
    • 市場佔有率與其預測
      • 各類型產品 (創傷、燒燙傷等)
      • 各地區
      • 各企業

第6章 各地區的市場展望

  • 北美市場
    • 市場規模與其預測 (以金額為準)
    • 市場佔有率與其預測
      • 各國
      • 各應用領域 (整形外科、牙科、皮膚替代品等)
  • 歐洲市場
  • 南美市場
  • 亞太地區市場
  • 中東、非洲市場

第7章 市場動態

  • 推動市場要素
  • 市場課題

第8章 市場趨勢與發展

  • 組織工程的奈米技術
  • 生物用3D印表機的組織工程的進步
  • 在取向骨組織工程的持續性革新
  • 適合慢性創傷治療的組織工程的利用擴大
  • 組織工程的改變蛋白質的利用增加
  • 組織工程、生醫材料的整形外科的革命性變化
  • 組織工程:眼科的未來性
  • 組織工程研究的幹細胞的利用增加

第9章 競爭環境

  • 競爭力比較分析
  • 企業簡介
    • Medtronic plc
    • Stryker Corporation
    • Zimmer Biomet
    • DePuy Synthes
    • Edwards Lifesciences Corporation
    • Smith & Nephew
    • Geistlich Pharma AG
    • Organogenesis Inc.
    • Institut Straumann AG
    • CryoLife, Inc.
    • Dentsply International
    • Integra LifeSciences Corporation
    • MiMedx Group, Inc.
    • St. Jude Medical, Inc.
    • B. Braun Melsungen AG
    • Wright Medical Technology, Inc.
    • ACE Surgical Supply Company, Inc.
    • BioHorizons IPH, Inc.
    • Botiss Biomaterials GmbH
    • Cytograft Tissue Engineering
    • Molnlycke Health Care
    • TEI Biosciences

第10章 策略性建議

圖表一覽

目錄

Tissue engineering involves biomaterial development and practice of combining cells, scaffolds and biologically active molecules into fully functional tissues and organs, for implantation in the living beings. This technology is used for making reconstructive implants that are used for replacing malfunctioned tissues and organs. Tissue engineered medical devices being more bio-compatible in comparison to artificial implants are preferred for treatment surgeries. Moreover, lower probability of rejection by human autoimmune system is also boosting its adoption among the physicians and patients requiring implants.

According to Pharmaion report, "Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020 ", global tissue engineered medical devices market is anticipated to surpass US$ 26 billion by 2020 on account of increasing prevalence of diabetes, aging population and increasing demand for tissue engineered medical devices over artificial implants. North America dominated the global tissue engineered medical devices market in 2014, and is anticipated to continue its dominance through 2020 as the percentage of geriatric population is very high in this region. Moreover, the economic stability of the region also helps patients to undergo expensive treatment options. Few of the leading companies operating in global tissue engineered medical devices market include Medtronic plc, Stryker Corporation, Zimmer Biomet, Edwards Lifesciences Corporation and Depuy Synthes, among others. "Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020 " report elaborates the following aspects of global tissue engineered medical devices market:

  • Global Tissue Engineered Medical Market Size, Volume, Share & Forecast
  • Segmental Analysis - Orthopedic Tissue, Cardiac Tissue, Dental Tissue & Skin Substitutes
  • Regional Analysis - North America, Europe, South America, Asia-Pacific, and Middle East & Africa
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • To gain an in-depth understanding of global tissue engineered medical devices market
  • To identify the on-going trends and anticipated growth in the next five years
  • To help industry consultants, tissue engineered medical device manufacturers, vendors and dealers align their market-centric strategies
  • To obtain research based business decisions and add weight to presentations and marketing material
  • To gain competitive knowledge of leading market players
  • To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer's specific needs

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary researchincluded interviews with tissue engineered medical devices producers and industry experts. Secondary researchincluded an exhaustive search of relevant publications like company annual reports, financial reports and other

Table of Contents

1. Research Methodology

2. Analyst View

3. Tissue Engineering Overview

4. Global Tissue Engineered Medical Devices Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
    • 4.2.2. By Source (Synthetic Biomaterials & Natural Biomaterials)
    • 4.2.3. By Region
    • 4.2.4. By Company
  • 4.3. Quality Control Policies

5. Global Tissue Engineered Medical Devices Segmental Market Outlook

  • 5.1. Global Orthopedic Tissue Engineered Medical Devices Market Outlook
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. Market Share & Forecast
      • 5.1.2.1. By Product Type (Biologics, Bone Graft & Bone Graft Substitute)
      • 5.1.2.2. By Region
      • 5.1.2.3. By Company
  • 5.2. Global Cardiac Tissue Engineered Medical Devices Market Outlook
    • 5.2.1. Market Share & Forecast
      • 5.2.1.1. By Value
      • 5.2.1.2. By Volume
    • 5.2.2. Market Share & Forecast
      • 5.2.2.1. By Product Type (Heart Valves & Vascular Grafts)
      • 5.2.2.2. By Region
      • 5.2.2.3. By Company
  • 5.3. Global Dental Tissue Engineered Medical Devices Market Outlook
    • 5.3.1. Market Size & Forecast
      • 5.3.1.1. By Value
      • 5.3.1.2. By Volume
    • 5.3.2. Market Share & Forecast
      • 5.3.2.1. By Product Type (Dental Membrane & Dental Bone Graft)
      • 5.3.2.2. By Region
      • 5.3.2.3. By Company
  • 5.4. Global Skin Substitutes Engineered Medical Devices Market Outlook
    • 5.4.1. Market Size & Forecast
      • 5.4.1.1. By Value
      • 5.4.1.2. By Volume
    • 5.4.2. Market Share & Forecast
      • 5.4.2.1. By Application (Wound, Burn & Others)
      • 5.4.2.2. By Region
      • 5.4.2.3. By Company

6. Global Tissue Engineered Medical Devices Regional Market Outlook

  • 6.1. North America Tissue Engineered Medical Devices Market Outlook
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. By Value
    • 6.1.2. Market Share & Forecast
      • 6.1.2.1. By Country
      • 6.1.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
  • 6.2. Europe Tissue Engineered Medical Devices Market Outlook
    • 6.2.1. Market Size & Forecast
      • 6.2.1.1. By Value
    • 6.2.2. Market Share & Forecast
      • 6.2.2.1. By Country
      • 6.2.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
  • 6.3. South America Tissue Engineered Medical Devices Market Outlook
    • 6.3.1. Market Size & Forecast
      • 6.3.1.1. By Value
    • 6.3.2. Market Share & Forecast
      • 6.3.2.1. By Country
      • 6.3.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
  • 6.4. Asia-Pacific Tissue Engineered Medical Devices Market Outlook
    • 6.4.1. Market Size & Forecast
      • 6.4.1.1. By Value
    • 6.4.2. Market Share & Forecast
      • 6.4.2.1. By Country
      • 6.4.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)
  • 6.5. Middle East & Africa Tissue Engineered Medical Devices Market Outlook
    • 6.5.1. Market Size & Forecast
      • 6.5.1.1. By Value
    • 6.5.2. Market Share & Forecast
      • 6.5.2.1. By Country
      • 6.5.2.2. By Application (Orthopedic, Cardiovascular, Dental, Skin Substitute & Others)

7. Market Dynamics

  • 7.1. Drivers
  • 7.2. Challenges

8. Market Trends & Developments

  • 8.1. Nanotechnology in Tissue Engineering
  • 8.2. 3D Bioprinting Advancing the Tissue Engineering
  • 8.3. Bone Tissue Engineering Witnessing Continuous Innovation
  • 8.4. Increasing Use of Tissue Engineered for Chronic Wound Healing
  • 8.5. Rising Application of Engineered Protein in Tissue Engineering
  • 8.6. Tissue Engineering and Biomaterials to Revolutionize Plastic Surgery Industry
  • 8.7. Tissue Engineering: Future of Ophthalmology
  • 8.8. Escalating Use of Stem Cells in Tissue Engineering Research

9. Competitive Landscape

  • 9.1. Competition Benchmarking
  • 9.2. Company Profiles
    • 9.2.1. Medtronic plc
    • 9.2.2. Stryker Corporation
    • 9.2.3. Zimmer Biomet
    • 9.2.4. DePuy Synthes
    • 9.2.5. Edwards Lifesciences Corporation
    • 9.2.6. Smith & Nephew
    • 9.2.7. Geistlich Pharma AG
    • 9.2.8. Organogenesis Inc.
    • 9.2.9. Institut Straumann AG
    • 9.2.10. CryoLife, Inc.
    • 9.2.11. Dentsply International
    • 9.2.12. Integra LifeSciences Corporation
    • 9.2.13. MiMedx Group, Inc.
    • 9.2.14. St. Jude Medical, Inc.
    • 9.2.15. B. Braun Melsungen AG
    • 9.2.16. Wright Medical Technology, Inc.
    • 9.2.17. ACE Surgical Supply Company, Inc.
    • 9.2.18. BioHorizons IPH, Inc.
    • 9.2.19. Botiss Biomaterials GmbH
    • 9.2.20. Cytograft Tissue Engineering
    • 9.2.21. Mölnlycke Health Care
    • 9.2.22. TEI Biosciences

10. Strategic Recommendations

List of Figures

  • Figure 1: Global Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 2: United States Demand for Kidney Donor, 1990 & 2012
  • Figure 3: Global Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 4: Global Tissue Engineered Medical Devices Market Share, By Application, By Volume, 2010-2020F
  • Figure 5: Global Tissue Engineered Medical Devices Market Share, By Source, By Value, 2010-2020F
  • Figure 6: Global Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 7: Global Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 8: Cell Tissue Technology Laboratory's Document Structure
  • Figure 9: Global Orthopedic Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 10: Global Orthopedic Tissue Engineered Medical Devices Market Share, By Product Type, By Value, 2010-2020F
  • Figure 11: Global Orthopedic Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 12: Global Orthopedic Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 13: Global Cardiac Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 14: Global Cardiac Tissue Engineered Medical Devices Market Share, By Product Type, By Value, 2010-2020F
  • Figure 15: Global Cardiac Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 16: Global Cardiac Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 17: Global Dental Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 18: Global Dental Tissue Engineered Medical Devices Market Share, By Product Type, By Value, 2010-2020F
  • Figure 19: Global Dental Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 20: Global Dental Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 21: Global Skin Substitute Tissue Engineered Medical Devices Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F
  • Figure 22: Global Skin Substitute Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 23: United States Statistics of Burn Injuries, 2013
  • Figure 24: Global Skin Substitute Tissue Engineered Medical Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 25: Global Skin Substitute Tissue Engineered Medical Devices Market Share, By Company, By Value, 2014 & 2020F
  • Figure 26: North America Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 27: North America Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 28: United States Prevalence of Cardiovascular Disease in Adults above 20 years of Age, By Age, By Sex, 2015 (% of total population)
  • Figure 29: United States Percentage Breakdown of Deaths due to Cardiovascular Disease, 2011
  • Figure 30: North America Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 31: Europe Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 32: Europe Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 33: Europe Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 34: South America Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 35: South America Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 36: South America Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 37: Asia-Pacific Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 38: Asia-Pacific Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 39: Asia-Pacific Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 40: Middle East & Africa Tissue Engineered Medical Devices Market Size, By Value (USD Billion), 2010-2020F
  • Figure 41: Middle East & Africa Tissue Engineered Medical Devices Market Share, By Country, By Value, 2010-2020F
  • Figure 42: Middle East & Africa Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F
  • Figure 43: Percentage of Natural Sources Used for Synthesis of Nanoparticles
  • Figure 44: Percentage of Plant and Animal Based Materials Used for Synthesis of Nanoparticles
  • Figure 45: Global 3D Printing Market Size, By Value (USD Million), 2010-2020F
  • Figure 46: Global Bone Graft Market Size, By Value (USD Million), 2010-2020F
  • Figure 47: Global Tissue Engineered Skin Substitute for Wound Healing Market Size, By Value (USD Million), 2010-2020F
  • Figure 48: Worldwide Wound Incidence, 2014
  • Figure 49: Global Protein Engineering Market Size, By Value, 2010-2020F (USD Million)

List of Tables

  • Table 1: Global Tissue Engineered Medical Devices Market Size, By Source (USD Million)
  • Table 2: Number of Diabetic Patients, By Country, 2013 (Million)
  • Table 3: United States Statistics of Gum Diseases, 2012
  • Table 4: Global Prevalence of Diabetes, 2012
  • Table 5: Canada Population Projections for Over 65 Years of Age, 1971 - 2061F (%)
  • Table 6: Middle East Healthcare Expenditure, 2010
Back to Top